Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Brian A. Crowe"'
Autor:
Agostina Carestia, Seok-Joo Kim, Franziska Horling, Hanspeter Rottensteiner, Christian Lubich, Birgit M. Reipert, Brian A. Crowe, Craig N. Jenne
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 95-108 (2021)
Adeno-associated viruses (AAVs) are emerging as one of the vehicles of choice for gene therapy. However, the potential immunogenicity of these vectors is a major limitation of their use, leading to the necessity of a better understanding of how viral
Externí odkaz:
https://doaj.org/article/f9b06ca4620a45d3afde7ccb0fe02637
Autor:
Dorit Lehmann, Sabine Unterthurner, Verena Berg, Karin Hock, Padmapriya Ponnuswamy, Mantas Malisauskas, Brian A. Crowe, Bekir Erguener, Christoph Bock, Greg Hather, Birgit M. Reipert, Ivan Bilic
Publikováno v:
ImmunoMedicine, Vol 1, Iss 2, Pp n/a-n/a (2021)
Abstract The balance of activating and inhibitory signals from the low affinity Fc gamma receptors modulates immune responses triggered by IgG antibody‐immune complexes. In homeostasis, this leads to antigen clearance, while in autoimmune diseases
Externí odkaz:
https://doaj.org/article/226f797ef5064991b1804e9d0932ca01
Autor:
Alexander Puck, Katharina Radakovics, Birgit M. Reipert, Madhura Modak, Peter Steinberger, Brian A. Crowe, Sarojinidevi Künig, Johannes Stöckl, Claire Battin, Lara May, Pia Fritz
Publikováno v:
European Journal of Immunology. 51:3176-3185
The soluble cytoplasmic tail of CD45 (ct-CD45) is a cleavage fragment of CD45, that is generated during the activation of human phagocytes. Upon release to the extracellular space, ct-CD45 binds to human T cells and inhibits their activation in vitro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c985a03b0c508a5e13e52375bdd48177
https://doi.org/10.1002/eji.202149227
https://doi.org/10.1002/eji.202149227
Autor:
Birgit M. Reipert, Franziska Horling, Christian Lubich, Seok-Joo Kim, Agostina Carestia, Craig N. Jenne, Brian A. Crowe, Hanspeter Rottensteiner
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 95-108 (2021)
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 95-108 (2021)
Adeno-associated viruses (AAVs) are emerging as one of the vehicles of choice for gene therapy. However, the potential immunogenicity of these vectors is a major limitation of their use, leading to the necessity of a better understanding of how viral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b55368657361708e566edfdde0c9a5c2
http://europepmc.org/articles/PMC7750493
http://europepmc.org/articles/PMC7750493
Autor:
Claire Battin, Sarojinidevi Künig, Katharina Radakovics, Brian A. Crowe, Alexander Puck, Lara May, Peter Steinberger, Johannes Stöckl, Pia Fritz, Birgit M. Reipert, Madhura Modak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81999c6ab15878dc4ed557e235eab39f
https://doi.org/10.1002/eji.202149227/v2/response1
https://doi.org/10.1002/eji.202149227/v2/response1
Autor:
Annett Hessel, Helga Savidis-Dacho, Sogue Coulibaly, Daniel Portsmouth, Thomas R Kreil, Brian A Crowe, Michael G Schwendinger, Andreas Pilz, P Noel Barrett, Falko G Falkner, Birgit Schäfer
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88340 (2014)
BACKGROUND: The availability of a universal influenza vaccine able to induce broad cross-reactive immune responses against diverse influenza viruses would provide an alternative to currently available strain-specific vaccines. We evaluated the abilit
Externí odkaz:
https://doaj.org/article/fe46820da6be43fb9b924fc38d53fccf
Autor:
Michael G Schwendinger, Maria O'Rourke, Andreas Traweger, Helga Savidis-Dacho, Andreas Pilz, Daniel Portsmouth, Ian Livey, P Noel Barrett, Brian A Crowe
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79022 (2013)
For clinical development of a novel multivalent OspA vaccine against Lyme borreliosis, serological assays are required which can be used to establish immune correlates of protection against infection with Borrelia.Four assays (an OspA IgG ELISA, a co
Externí odkaz:
https://doaj.org/article/f170d856f9814aa49efee399e5f88620
Autor:
Birgit Schäfer, Georg W Holzer, Alexandra Joachimsthaler, Sogue Coulibaly, Michael Schwendinger, Brian A Crowe, Thomas R Kreil, P Noel Barrett, Falko G Falkner
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24505 (2011)
BACKGROUND: Currently existing yellow fever (YF) vaccines are based on the live attenuated yellow fever virus 17D strain (YFV-17D). Although, a good safety profile was historically attributed to the 17D vaccine, serious adverse events have been repor
Externí odkaz:
https://doaj.org/article/8754ddabd43445ef9a1b4f87c1302bc2
Autor:
Annett Hessel, Michael Schwendinger, Georg W Holzer, Klaus K Orlinger, Sogue Coulibaly, Helga Savidis-Dacho, Marie-Luise Zips, Brian A Crowe, Thomas R Kreil, Hartmut J Ehrlich, P Noel Barrett, Falko G Falkner
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e16247 (2011)
BACKGROUND: New highly pathogenic H5N1 influenza viruses are continuing to evolve with a potential threat for an influenza pandemic. So far, the H5N1 influenza viruses have not widely circulated in humans and therefore constitute a high risk for the
Externí odkaz:
https://doaj.org/article/aa02955da4be48a892c3e65736b41f70
Autor:
Annett Hessel, Michael Schwendinger, Daniela Fritz, Sogue Coulibaly, Georg W Holzer, Nicolas Sabarth, Otfried Kistner, Walter Wodal, Astrid Kerschbaum, Helga Savidis-Dacho, Brian A Crowe, Thomas R Kreil, P Noel Barrett, Falko G Falkner
Publikováno v:
PLoS ONE, Vol 5, Iss 8, p e12217 (2010)
BACKGROUND: The development of novel influenza vaccines inducing a broad immune response is an important objective. The aim of this study was to evaluate live vaccines which induce both strong humoral and cell-mediated immune responses against the no
Externí odkaz:
https://doaj.org/article/2b24e378b3064e2aa532a5ed5adbfba7